{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T17:48:41Z","timestamp":1782755321807,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,8,25]],"date-time":"2009-08-25T00:00:00Z","timestamp":1251158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1007\/s10620-009-0942-x","type":"journal-article","created":{"date-parts":[[2009,8,24]],"date-time":"2009-08-24T16:27:37Z","timestamp":1251131257000},"page":"1696-1703","source":"Crossref","is-referenced-by-count":50,"title":["Mesalamine Protects Against Colorectal Cancer in Inflammatory Bowel Disease"],"prefix":"10.1007","volume":"55","author":[{"given":"Jeffrey","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Sharif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetan","family":"Pai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann L.","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,8,25]]},"reference":[{"key":"942_CR1","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z","volume":"91","author":"CN Bernstein","year":"2001","unstructured":"Bernstein CN, Blanchard JF, Kliewer E, et\u00a0al. Cancer risk in patients with inflammatory bowel disease. Cancer. 2001;91:854\u2013862.","journal-title":"Cancer"},{"key":"942_CR2","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/gut.48.4.526","volume":"48","author":"JA Eaden","year":"2001","unstructured":"Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001;48:526\u2013535.","journal-title":"Gut"},{"key":"942_CR3","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJM199011013231802","volume":"323","author":"A Ekbom","year":"1990","unstructured":"Ekbom A, Helmick C, Zack M, et\u00a0al. Ulcerative colitis and colorectal cancer. N Engl J Med. 1990;323:1228\u20131233.","journal-title":"N Engl J Med"},{"key":"942_CR4","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1002\/1097-0142(19811215)48:12<2742::AID-CNCR2820481231>3.0.CO;2-P","volume":"48","author":"AJ Greenstein","year":"1981","unstructured":"Greenstein AJ, Sachar DB, Smith H, et\u00a0al. A comparison of cancer risk in crohn\u2019s disease and ulcerative colitis. Cancer. 1981;48:2742\u20132745.","journal-title":"Cancer"},{"key":"942_CR5","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0889-8553(05)70065-0","volume":"28","author":"JD Lewis","year":"1999","unstructured":"Lewis JD, Deren JJ, Lichtenstein GR. Cancer risk in patients with inflammatory bowel disease. Gastroenterol Clin North Am. 1999;28:459\u2013477.","journal-title":"Gastroenterol Clin North Am"},{"key":"942_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2036.18.s2.2.x","volume":"18","author":"P Munkholm","year":"2003","unstructured":"Munkholm P. Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease. Aliment Pharmacol Ther. 2003;18:1\u20135.","journal-title":"Aliment Pharmacol Ther"},{"key":"942_CR7","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1572-0241.2007.01070.x","volume":"102","author":"T Jess","year":"2007","unstructured":"Jess T, Loftus EV, Velayos FS, et\u00a0al. Risk factors for colorectal neoplasia in inflammatory bowel disease: a nested case-control study from Copenhagen County, Denmark and Olmsted County, Minnesota. Am J Gastroenterol. 2007;102:829\u2013836.","journal-title":"Am J Gastroenterol"},{"key":"942_CR8","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/j.gastro.2003.11.010","volume":"126","author":"M Rutter","year":"2004","unstructured":"Rutter M, Saunders B, Wilkinson K, et\u00a0al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology. 2004;126:451\u2013459.","journal-title":"Gastroenterology"},{"key":"942_CR9","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0140-6736(07)60751-X","volume":"369","author":"DC Baumgart","year":"2007","unstructured":"Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet. 2007;369:1641\u20131657.","journal-title":"Lancet"},{"key":"942_CR10","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/j.1572-0241.2004.40036.x","volume":"99","author":"A Kornbluth","year":"2004","unstructured":"Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults (update): American college of gastroenterology, practice parameters committee. Am J Gastroenterol. 2004;99:1371\u20131385.","journal-title":"Am J Gastroenterol"},{"key":"942_CR11","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1111\/j.1572-0241.2003.08718.x","volume":"98","author":"CN Bernstein","year":"2003","unstructured":"Bernstein CN, Blanchard JF, Metge C, et\u00a0al. Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer? Am J Gastroenterol. 2003;98:2784\u20132788.","journal-title":"Am J Gastroenterol"},{"issue":"11 Pt1","key":"942_CR12","first-page":"1262","volume":"12","author":"J Carrier","year":"2003","unstructured":"Carrier J, Medline A, Sohn KJ, et\u00a0al. Effects of dietary folate on ulcerative colitis-associated colorectal carcinogenesis in the interleukin w- and beta (2) - microglobulin-deficient mice. Cancer Epidemiol Biomarkers Prev. 2003;12(11 Pt1):1262\u201312167.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"942_CR13","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.gtc.2006.07.003","volume":"35","author":"EP Chan","year":"2006","unstructured":"Chan EP, Lichtenstein GR. Chemoprevention: risk reduction with medical therapy of inflammatory bowel disease. Gastroenterol Clin North Am. 2006;35:675\u2013712.","journal-title":"Gastroenterol Clin North Am"},{"key":"942_CR14","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3748\/wjg.v11.i3.309","volume":"11","author":"Y Cheng","year":"2005","unstructured":"Cheng Y, Desreumaux P. 5-aminosalicylic acid is an attractive candidate agent for chemoprevention of colon cancer in patients with inflammatory bowel disease. World J Gastroenterol. 2005;11:309\u2013314.","journal-title":"World J Gastroenterol"},{"key":"942_CR15","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1002\/ibd.20489","volume":"14","author":"ML Clapper","year":"2008","unstructured":"Clapper ML, Gary MA, Coudry RA, et\u00a0al. 5-Aminosalicylic acid inhibits colitis-associated colorectal dysplasias in the mouse model of azoymethane\/dextran sulfate sodium-induced colitis. Inflamm Bowel Dis. 2008;14:1341\u20131347.","journal-title":"Inflamm Bowel Dis"},{"key":"942_CR16","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s00384-002-0476-6","volume":"18","author":"VJ Croog","year":"2003","unstructured":"Croog VJ, Ullman TA, Itzkowitz SH. Chemoprevention of colorectal cancer in ulcerative colitis. Int J Colorectal Dis. 2003;18:392\u2013400.","journal-title":"Int J Colorectal Dis"},{"key":"942_CR17","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1046\/j.1365-2036.2000.00698.x","volume":"14","author":"J Eaden","year":"2000","unstructured":"Eaden J, Abrams K, Ekbom A, et\u00a0al. Colorectal cancer prevention in ulcerative colitis: a case-control study. Aliment Pharmacol Ther. 2000;14:145\u2013153.","journal-title":"Aliment Pharmacol Ther"},{"key":"942_CR18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0016-5085(97)70215-4","volume":"112","author":"BA Lashner","year":"1997","unstructured":"Lashner BA, Provencher KS, Seidner DL, et\u00a0al. The effect of folic acid supplements on the risk for cancer or dysplasia in ulcerative colitis. Gastroenterology. 1997;112:29\u201332.","journal-title":"Gastroenterology"},{"key":"942_CR19","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/00042737-199612000-00009","volume":"8","author":"GA Moody","year":"1996","unstructured":"Moody GA, Jayanthi V, Probert CSJ, et\u00a0al. Long-term therapy with sulfasalazine protects against colorectal cancer in ulcerative colitis: a retrospective study of colorectal cancer risk and compliance with treatment in Leicestershire. Eur J Gastroenterol Hepatol. 1996;8:1179\u20131183.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"942_CR20","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/ibd.20297","volume":"14","author":"DT Rubin","year":"2008","unstructured":"Rubin DT, Cruz-Correa MR, Gashe C, et\u00a0al. Colorectal cancer prevention in inflammatory bowel disease and the role of 5-aminosalicylic acid: A clinical review and update. Inflamm Bowel Dis. 2008;14:265\u2013274.","journal-title":"Inflamm Bowel Dis"},{"key":"942_CR21","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.cgh.2006.08.014","volume":"4","author":"DT Rubin","year":"2006","unstructured":"Rubin DT, LoSavio A, Yadron N, et\u00a0al. Aminosalicylate therapy in the prevention of dysplasia and colorectal cancer in ulcerative colitis. Clin Gastroenterol Hepatol. 2006;4:1346\u20131350.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"942_CR22","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1067\/mlc.2001.117161","volume":"138","author":"BM Ryan","year":"2001","unstructured":"Ryan BM, Weir DG. Relevance of folate metabolism in the pathogenesis of colorectal cancer. J Lab Clin Med. 2001;138:164\u2013176.","journal-title":"J Lab Clin Med"},{"key":"942_CR23","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1111\/j.1572-0241.2003.07599.x","volume":"98","author":"BM Ryan","year":"2003","unstructured":"Ryan BM, Russel MGVM, Langholz E, et\u00a0al. Aminosalicylates and colorectal cancer in IBD: a not-so bitter pill to swallow. Am J Gastroenterol. 2003;98:1682\u20131687.","journal-title":"Am J Gastroenterol"},{"key":"942_CR24","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/ibd.20074","volume":"13","author":"JP Terdiman","year":"2007","unstructured":"Terdiman JP, Steinbuch M, Blumentals WA, et\u00a0al. 5-aminosalicylatic therapy and the risk of colorectal cancer among patients with inflammatory bowel disease. Inflamm Bowel Dis. 2007;13:367\u2013371.","journal-title":"Inflamm Bowel Dis"},{"key":"942_CR25","doi-asserted-by":"crossref","first-page":"6115","DOI":"10.3748\/wjg.v12.i38.6115","volume":"12","author":"AA Bodegraven Van","year":"2006","unstructured":"Van Bodegraven AA, Mulder CJJ. Indications for 5-aminosalicylate in inflammatory bowel disease: is the body of evidence complete? World J Gastroenterol. 2006;12:6115\u20136123.","journal-title":"World J Gastroenterol"},{"key":"942_CR26","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1136\/gut.2005.070896","volume":"54","author":"TP Staa Van","year":"2005","unstructured":"Van Staa TP, Card T, Logan RF, et\u00a0al. 5-aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study. Gut. 2005;54:1573\u20131578.","journal-title":"Gut"},{"key":"942_CR27","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1111\/j.1572-0241.2005.41442.x","volume":"100","author":"FS Velayos","year":"2005","unstructured":"Velayos FS, Terdiman JP, Walsh JM. Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systemic review and metaanalysis of observational studies. Am J Gastroenterol. 2005;100:1345\u20131353.","journal-title":"Am J Gastroenterol"},{"key":"942_CR28","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1053\/gast.2001.24052","volume":"120","author":"J Askling","year":"2001","unstructured":"Askling J, Dickman PW, Karlen P, et\u00a0al. Family history as a risk factor for colorectal cancer in inflammatory bowel disease. Gastroenterology. 2001;120:1356\u20131362.","journal-title":"Gastroenterology"},{"key":"942_CR29","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/jamia.2001.0080610","volume":"8","author":"G Makoul","year":"2001","unstructured":"Makoul G, Curry RH, Tang PC. The use of electronic medical records: communication patterns in outpatient encounters. J Am Med Inform Assoc. 2001;8:610\u2013615.","journal-title":"J Am Med Inform Assoc"},{"key":"942_CR30","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/j.1365-2036.2006.02846.x","volume":"23","author":"R Bergman","year":"2006","unstructured":"Bergman R, Parkes M. Systemic review: the use of mesalamine in inflammatory bowel disease. Aliment Pharmacol Ther. 2006;23:841\u2013845.","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-009-0942-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-009-0942-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-009-0942-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T15:42:51Z","timestamp":1559230971000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-009-0942-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,25]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["942"],"URL":"https:\/\/doi.org\/10.1007\/s10620-009-0942-x","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,25]]}}}